Diaminopyrimidine Oxide identifies the ingredient you may also see called Kopexil. For a buyer, that name is the start of a specification. It does not tell you whether a shipment matches the sample your team tested. For a formulator, it is the start of a trial. It does not tell you whether the material stays uniform in a particular base.
At Maxmedchem, we manufacture diaminopyrimidine oxide powder for cosmetic raw material buyers. We want you to qualify the grade with a process your lab can repeat. That means checking the chemical identity, understanding the assay, and setting a clear way to accept or reject a commercial lot before you order.
Diaminopyrimidine Oxide Has an Identity You Can Put on a Purchase Order
Use three fields to pin down the material
Health Canada’s ingredient record lists the name Diaminopyrimidine Oxide and CAS 74638-76-9. PubChem records the formula C4H6N4O. Add the intended material form to the specification. A liquid containing the active, a dry powder, and a blend can share a listed component while presenting different handling and labeling needs.
Confirm the identity on the package, certificate, and technical data sheet. If one document refers to a blend and another to the neat ingredient, resolve the difference before sampling. Make sure any translation preserves the full chemical name. A short name used in a quotation can be useful, but your acceptance criteria should refer to the actual material.
Treat the specification as a purchase standard
The public product listing describes a white powder and a 98% HPLC specification. Request a representative lot certificate and the test method. Ask whether the result is a peak-area percentage, a dry-basis mass assay, or an as-received mass assay. Your team needs that answer before it uses the number to set the batch weight.
Separate a range or minimum on a specification from a measured result on a certificate. For example, a limit can define the lowest acceptable assay. A specific lot can meet that limit with a different reported value. Use the correct value for each decision and record which one you used.

Diaminopyrimidine Oxide Needs a Verified Assay Basis
Put the active calculation on the batch sheet
Assume an illustrative 250 kg pilot calls for 0.32% active by weight. The batch needs 0.80 kg of active. If the tested material has a verified 98% mass assay as received, the estimated powder weight is about 0.816 kg. Count that powder in the total batch weight. These numbers explain the calculation and do not recommend a use level.
If the certificate reports a dry-basis result, ask your quality team how it should be applied. A moisture value, volatile loss, and HPLC area result each describe a different measurement. Do not subtract one from another without knowing what the method measures. Agree on the rule before an operator weighs the first lot.
Ask what the assay can measure in the finished base
The test used on a powder may not work in shampoo or a thick conditioner without changes. The lab needs to recover the active from the base and measure it without confusing it with other ingredients. Discuss how the method will handle the actual product if you plan to use it for stability or release.
Set the sample plan along with the method. A single sample from the top of a vessel may miss a mixing problem. At pilot scale, consider drawing samples from defined locations or times. Keep the conditions the same when you compare a lab batch with a plant batch. That gives you a better test of uniformity.
Diaminopyrimidine Oxide Qualification Should Include a Scale-Up Check
Make a matched base and a trial using the sample grade. Note the addition order, pH, temperature, and mixing time. If the powder needs a premix, keep a record of its carrier and how long it sits before use. Those details help your team find a cause if a sample develops haze or deposits after cooling.
Run a small storage check in the intended pack. Observe whether the appearance, viscosity, pH, and active content stay within your planned limits. A batch can look clear at the bench and change after it sits. Build time for that change into your release plan instead of promising a launch date based on the first day alone.
At scale, the same mixing time may not produce the same result. Equipment geometry, ingredient addition point, and the speed of heating or cooling can change the process. A qualified lab sample shows that the formula can work. A scale-up lot shows whether the production method can repeat it. Record both as separate gates in the buying plan.
Keep a retained sample of the material and link it to the batch record. If a later lot behaves differently, you can compare it with the material that passed the pilot. Use our cosmetic ingredient catalog when you qualify multiple raw materials for the same line. Keep the file for each grade separate even if the materials arrive together.
Review the sampling plan before your first commercial shipment arrives. If you receive several containers, decide how to select them and how to keep each sample tied to its container and lot. Ask the quality team to state whether it needs a single sample or several separate samples. Combining samples can make testing easier, but it can also hide a difference between containers.
Plan what to do while the material is on hold. Give the warehouse a clear label and storage instructions, and tell production which records it needs before use. A good release step keeps an unapproved shipment out of a batch without delaying the entire line.
Ask your formulator to keep a simple comparison file. Include the bench formula, the pilot results, and the tested material’s lot number. When a new quote comes in, you can use that file to see which checks the new supplier needs to repeat. This gives procurement a way to qualify a backup source without guessing how much testing to budget.

Diaminopyrimidine Oxide: Write a Quote That Covers Release
Ask the supplier for a wholesale price tied to a grade, packaging, quantity, and delivery location. Include the minimum order quantity, sample lead time, commercial lead time, and trade terms in your comparison. Confirm whether the price includes the tests and documents required by your quality team. A low unit price can be misleading if it leaves out a critical release check.
The purchase order should state what you need before shipment. For instance, request a current lot certificate, identity and assay method, storage conditions, and any relevant impurity limits. Ask how the manufacturer will tell you if a process or specification changes. Keep the change notice tied to the exact material so your team knows which formulas to review.
Check the intended market with your assessor before you scale. EU Annex III lists the substance in entry 93 with a 1.5% maximum for the listed ready-to-use hair products. A legal ceiling is not a formulation target. Your team still needs to review the full formula, exposure, and intended claims.
Our practical rule is to pay for reproducibility. A sample, a clear certificate, and a documented route from the lab to the plant are worth more than an unexplained purity headline. See the Maxmedchem diaminopyrimidine oxide powder supply process and ask us to match the sample and commercial quotation to your specification.
Request a diaminopyrimidine oxide sample and bulk quote. Contact us with your target market, grade, lot checks, pilot size, annual demand, and delivery location.
FAQs
What is the CAS number?
74638-76-9. Confirm it alongside the INCI name and form.
What is the molecular formula?
PubChem lists C4H6N4O.
Is every 98% HPLC result a mass assay?
Ask for the method and basis. A peak-area result alone cannot tell you the weight of active.
What should I test before switching suppliers?
Compare identity, active basis, compatibility, and stability in the actual base using representative samples.
When should I request a commercial lot certificate?
Specify the required tests during quotation and confirm the actual lot before release.
References
Health Canada, Diaminopyrimidine Oxide ingredient entry. Identity and CAS record.
PubChem, compound 10197687. Substance identity and molecular formula.
EU Cosmetics Regulation, Annex III, entry 93. Restriction for the listed cosmetic category.
European Commission, CosIng guidance. Role of the cosmetic ingredient inventory.